Randomized trial of aspirin, sibrafiban, or both for secondary prevention after acute coronary syndromes.
摘要：
Combining aspirin with LDS did not improve outcomes after acute coronary syndromes and caused more bleeding compared with aspirin alone. There was a trend toward increased mortality in this group and a significant increase in the high-dose arm.
展开
DOI：
10.1016/S1062-1458(01)00370-1
被引量：
年份：
2001
相似文献
参考文献
引证文献
来源期刊
Acc Current Journal Review
September–October 2001
引用走势
2002
被引量：34
辅助模式
0
引用
文献可以批量引用啦~
欢迎点我试用！
